Effects of empagliflozin in patients at risk of heart failure: the empire prevent metabolic trial - Top-Institutions - MDSpire

Effects of empagliflozin in patients at risk of heart failure: the empire prevent metabolic trial

  • By

  • Camilla Fuchs Andersen

  • Julie Hempel Larsen

  • Massar Omar

  • Nina Nouhravesh

  • Caroline Michaela Kistorp

  • Christian Tuxen

  • Filip K Knop

  • Per Lav Madsen

  • Julie Lyng Forman

  • Filip Søskov Davidovski

  • Lars Køber

  • Morten Schou

  • Jacob Eifer Møller

  • Jesper Jensen

  • January 8, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Metabolic Disease

  • #2

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Endocrinology
    • Heart Failure

  • #3

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Metabolic Research

  • #4

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Metabolism
    • Heart Failure

  • #5

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Heart Failure
    • Endocrinology

Original Source(s)

Effects of empagliflozin in patients at risk of heart failure: the empire prevent metabolic trial

  • by Camilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, Nina Nouhravesh, Caroline Michaela Kistorp, Christian Tuxen, Filip K Knop, Per Lav Madsen, Julie Lyng Forman, Filip Søskov Davidovski, Lars Køber, Morten Schou, Jacob Eifer Møller, Jesper Jensen

  • January 8, 2026

Related Content

Visceral fat area and visceral-to-subcutaneous fat ratio are more strongly associated with residual cholesterol than conventional anthropometric indices in adults with type 2 diabetes

Heart failure risk prediction based on machine learning and interpretability analysis

The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions